The MHRA have extended their fee waiver programme for UK micro and small enterprises developing innovative medical devices. The updated programme will run from 20 April 2026 to 5 April 2027, following evaluation of the initial pilot. Based on feedback, they have introduced two key changes: The programme now includes some Class III medical devices The MHRA will now review…
Ben KempApril 28, 2026